Uric acid: a major candidate for protective treatment of after-effects in stroke patients
Stroke is a very common disease that continues to be the second highest cause of death in the world, and the top cause of permanent disability. Altho1
Stroke is a very common disease that continues to be the second highest cause of death in the world, and the top cause of permanent disability. Altho1
The pandemic has increased anxiety and stress in the general population, but when it comes to people with mental illnesses such as obsessive compulsi1
COVID-19 affects people with Parkinson’s disease in a similar way to the general population, but it may be more serious in cases of advanced disease.1
The pandemic and lockdown caused by COVID-19 have increased symptoms of anxiety and depression in the population. However, according to a major surve1
Lockdown situations can lead to feelings of stress, frustration, guilt, or even anxiety in the general public. Also, people with mental disorders are1
Schizophrenia is a very heterogeneous disease, patients who suffer this may present a variety of symptoms. In addition, there is currently no analyti1
Intervention in the early stages of psychosis is fundamental, as delay in the detection and treatment of the first psychotic episode is associated wi1
Researchers from the Institute of Neurosciences of the University of Barcelona (UBNeuro), Hospital Clínic and the IDIBAPS have identified a group of1
Several studies have shown that different psychiatric disorders share a common denominator: inflammation forms part of their pathological mechanism.
Recent studies show that high pollution in the environment increases the risk of having a stroke According to the Spanish Society of Neurology (in S1